Zainab M. Doctor
Harvard University(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Protein Degradation and Inhibitors, Signaling Pathways in Disease, Ubiquitin and proteasome pathways, Traditional Chinese Medicine Studies
Most-Cited Works
- → Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation(2017)539 cited
- → A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader(2017)433 cited
- → SAICAR Induces Protein Kinase Activity of PKM2 that Is Necessary for Sustained Proliferative Signaling of Cancer Cells(2014)176 cited
- → Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells(2018)160 cited
- → Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo(2021)142 cited
- → Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis(2020)139 cited
- → Development and Characterization of a Wee1 Kinase Degrader(2019)100 cited
- → A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification(2018)90 cited
- → Identification of a potent and selective covalent Pin1 inhibitor(2020)84 cited
- → Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives(2016)60 cited